Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs myRocky

GobyMeds
Graded #142

Higher grade

vs+17.500000000000007
myRocky
Graded #487

Lower grade

The verdict

GobyMeds takes it — 68.9/100 to 51.4/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +33
67
34
Dose & formulationGobyMeds +22
75
53
Clinical oversightGobyMeds +18
82
64
Labs & monitoringGobyMeds +1
53
52
FulfillmentEven
70
70
Contract termsGobyMeds +14
55
41
GobyMeds · left barmyRocky · right bar

The numbers

MetricGobyMedsmyRocky
WeighScore68.9/10051.4/100
GradeCC
Scorecard rank#142#487
Semaglutide$169/mo (all doses, compounded)Not disclosed
Tirzepatide$299/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
GobyMeds

Graded #142 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard